These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2714049

  • 1. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
    Keidan AJ, Sowter MC, Johnson CS, Marwah SS, Stuart J.
    Clin Sci (Lond); 1989 Apr; 76(4):357-62. PubMed ID: 2714049
    [Abstract] [Full Text] [Related]

  • 2. Effect of BW12C on oxygen affinity of haemoglobin in sickle-cell disease.
    Keidan AJ, Franklin IM, White RD, Joy M, Huehns ER, Stuart J.
    Lancet; 1986 Apr 12; 1(8485):831-4. PubMed ID: 2870317
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.
    Keidan AJ, Sowter MC, Johnson CS, Noguchi CT, Girling AJ, Stevens SM, Stuart J.
    Br J Haematol; 1989 Apr 12; 71(4):551-7. PubMed ID: 2469459
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
    Green MA, Noguchi CT, Keidan AJ, Marwah SS, Stuart J.
    J Clin Invest; 1988 Jun 12; 81(6):1669-74. PubMed ID: 3384944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions.
    Dufu K, Patel M, Oksenberg D, Cabrales P.
    Clin Hemorheol Microcirc; 2018 Jun 12; 70(1):95-105. PubMed ID: 29660913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Rab MAE, van Oirschot BA, Bos J, Merkx TH, van Wesel ACW, Abdulmalik O, Safo MK, Versluijs BA, Houwing ME, Cnossen MH, Riedl J, Schutgens REG, Pasterkamp G, Bartels M, van Beers EJ, van Wijk R.
    Am J Hematol; 2019 May 12; 94(5):575-584. PubMed ID: 30784099
    [Abstract] [Full Text] [Related]

  • 19. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
    Strader MB, Liang H, Meng F, Harper J, Ostrowski DA, Henry ER, Shet AS, Eaton WA, Thein SL, Alayash AI.
    Bioconjug Chem; 2019 Mar 20; 30(3):568-571. PubMed ID: 30794381
    [Abstract] [Full Text] [Related]

  • 20. Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
    Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA.
    Blood; 2021 Sep 30; 138(13):1172-1181. PubMed ID: 34197597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.